VeinViewer Vein Finder to be Exhibited at AACN NTI

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Company spokesperson notes:  “VeinViewer is the only device of its kind to have a positive impact on a patient’s experience due to improved peripheral IV insertion,” says George Pinho, president, Christie Medical Holdings. “With ninety percent of hospital patients requiring venipuncture for a blood draw or IV insertion, we’re eager to demonstrate how VeinViewer can improve the quality of care for patients, especially those with difficult venous access.”

Christie® Medical Holdings will be displaying its industry leading lineup of VeinViewer near-infrared, vein finder technology at the 2017 National Teaching Institute and Critical Care Exposition, May 22-25 at the Houston George R. Brown Convention Center.

VeinViewer reduces the time needed for IV insertion, reduces the use of PICCs by up to 30 percent, and improves first stick success rates by up to 100 percent when starting an IV catheter. VeinViewer also aids in determining the point of insertion in venipuncture procedures by locating valves and venous bifurcations. VeinViewer uses near-infrared light to create a real-time digital image of a patient’s veins on their skin.

Company spokesperson notes:  “VeinViewer is the only device of its kind to have a positive impact on a patient’s experience due to improved peripheral IV insertion,” says George Pinho, president, Christie Medical Holdings. “With ninety percent of hospital patients requiring venipuncture for a blood draw or IV insertion, we’re eager to demonstrate how VeinViewer can improve the quality of care for patients, especially those with difficult venous access.”

Christie Medical Holdings is offering programs for nurses and clinicians to receive Continuing Education Recognition Points (CERPs) at three ExpoEd Sessions: First Stick Success: Technology Makes a Significant Impact; Overcoming Vascular Access Challenges; and Fewer Sticks and Fewer PICCs. ExpoEd sessions will be held in the Christie booth, number 4639.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.